Dapoxetine Impurity 14 CAS 2242008-38-2
| CAS No. | 2242008-38-2 |
| Molecular Formula | C30H31NO2 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Dapoxetine Impurity 14 is closely related to a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Dapoxetine Impurity 14 (CAS 2242008-38-2), a pharmacopoeial impurity reference standard (molecular formula C30H31NO2HCl, MW 474.04 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Dapoxetine Impurity 14 (C30H31NO2HCl) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Dapoxetine Impurity 14 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C30H31NO2 HCl |
| Molecular Weight | 474.04 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 15.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1998 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Dapoxetine Standards
- Dapoxetine Impurity 74 (CAS 100306-33-0)
- Dapoxetine Impurity 37 (CAS 100306-34-1)
- Dapoxetine Impurity 23 (CAS 102-93-2)
- Dapoxetine Impurity 86 (CAS 103548-16-9)
- rac-Dapoxetine HCL (CAS 1071929-03-7)
- Dapoxetine Impurity 34 (CAS 1083-30-3)
- Dapoxetine Impurity 18 (CAS 1091626-77-5)
- Dapoxetine-d7 HCl (CAS 1132642-56-8(free base))
Recommended Standards
- Imidafenacin Impurity 7 (CAS 214777-44-3)
- Tunodafil Impurity 5 (CAS CATO-C4X-31105)
- Nisoldipine Impurity 6 (CAS 61312-59-2)
- 2-amino-N-(5-bromo-2-methylphenyl)acetamide (CAS 1157171-39-5)
- 1346599-92-5 4-Methoxy-alpha-methyl-benzeneethanol-d6 (CAS 1346599-92-5)
- (3-Methylimidazo[1,2-a]pyridin-8-yl)methanol (CAS 167884-09-5)
- 3-(5-Methyl-2-(trifluoromethyl)phenyl)propanoic acid (CAS 1017779-28-0)
- benzyl acrylate-d3 (CAS 2226629-38-3)
- 4-Difluoromethanesulfinylaniline (CAS 24906-88-5)
- Semaglutide impurity 274 (CAS CATO-C4X-2226274)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com